Mankind Pharma Limited (NSE:MANKIND)

Market Cap	1.03T
Revenue (ttm)	116.41B
Net Income (ttm)	20.41B
Shares Out	412.58M
EPS (ttm)	50.81
PE Ratio	49.20
Forward PE	46.77
Dividend	n/a
Ex-Dividend Date	n/a

Volume	400,805
Average Volume	368,630
Open	2,500.00
Previous Close	2,500.00
Day's Range	2,500.00 - 2,564.70
52-Week Range	1,901.05 - 3,054.80
Beta	0.53
RSI	57.64
Earnings Date	May 15, 2025

About Mankind Pharma

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. It provides consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and m...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1991
• Employees: 19,540
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MANKIND

Financial Performance

In 2023, Mankind Pharma's revenue was 103.35 billion, an increase of 18.12% compared to the previous year's 87.49 billion. Earnings were 19.13 billion, an increase of 49.23%.